Luo & Wu (2019) verified that miR-375 may be a new prognostic marker of ESCC by meta-analysis. Pan et al. (2014) measured FOXCUT/FOXC1 in 82 ESCC tissues and adjacent noncancerous tissues by real-time quantitative PCR (qPCR), and found patients with upregulated FOXCUT or FOXC1 experienced a significantly worse prognosis than those with downregulated FOXCUT or FOXC1. The gene discussed is FOXCUT; the disease is esophageal squamous cell carcinoma.